Container closure integrity testing (CCIT) verifies that a sealed pharmaceutical container, such as a vial or syringe with its closure, will keep out contaminants and keep in product for the life of the container. Because regulators require validated leak-detection methods for sterile products, companies patent both the physical test apparatus and the validation methodology itself. That dual focus is why this dataset’s records cluster almost entirely in G01M, the testing-machinery classification, rather than spreading across packaging design classes.

In this dataset of 18 records, the ranking of 8 assignees is led by Lonza with 8 records, a steep step down to the next tier of filers, and a long tail of single-record filers including named individual inventors. This concentration means a competitive review should weight the leader’s filings heavily rather than treating the field as evenly contested. Smaller filers still matter where their specific claims overlap a planned product or method.

Filing activity in this dataset peaked in 2018 at 6 records and has not returned to that level since, with no completed filings recorded in the most recent full years. A formal growth rate cannot be computed from this evidence because fewer than four complete years remain once the roughly 18-month publication lag is accounted for. Readers should treat the most recent one to two years as understated rather than genuinely quiet.